The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Jun. 20, 2017
Applicants:

Stephane Bogen, Somerset, NJ (US);

David Dukhan, Montpellier, FR;

Guillaume Brandt, Grabels, FR;

Claire Pierra Rouviere, Montarnaud, FR;

Cyril B. Dousson, Canet, FR;

Francois-rene Alexandre, Montpellier, FR;

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Idenix Pharmaceuticals Llc, Campbridge, MA (US);

Inventors:

Stephane Bogen, Somerset, NJ (US);

David Dukhan, Montpellier, FR;

Guillaume Brandt, Grabels, FR;

Claire Pierra Rouviere, Montarnaud, FR;

Cyril B. Dousson, Canet, FR;

Francois-Rene Alexandre, Montpellier, FR;

Assignees:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Idenix Pharmaceuticals LLC, Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/11 (2006.01); A61P 31/14 (2006.01); C07H 19/213 (2006.01); A61K 45/06 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01);
U.S. Cl.
CPC ...
C07H 19/213 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01); C07H 19/11 (2013.01);
Abstract

The present invention relates to Cyclic Phosphate Substituted Nucleoside Compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein in A, B, R, R, R, Q and V are as defined herein. The present invention also relates to compositions comprising a Cyclic Phosphate Substituted Nucleoside Compound, and methods of using the Cyclic Phosphate Substituted Nucleoside Compounds for treating or preventing HCV infection in a patient.


Find Patent Forward Citations

Loading…